Renal Cancer Clinical Trials

A listing of Renal Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Tucson Arizona 85719

A clinical trial to evaluate treatments using RX-0201 and Everolimus for patients with Metastatic Renal Cell Cancer

California

Duarte California 91010

A clinical trial to evaluate treatments using RX-0201 and Everolimus for patients with Metastatic Renal Cell Cancer

Illinois

Chicago Illinois 60612

A clinical trial to evaluate treatments using RX-0201 and Everolimus for patients with Metastatic Renal Cell Cancer

Michigan

Grand Rapids Michigan 49503

A clinical trial to evaluate treatments using RX-0201 and Everolimus for patients with Metastatic Renal Cell Cancer

New Mexico

Albuquerque New Mexico 87106

A clinical trial to evaluate treatments using RX-0201 and Everolimus for patients with Metastatic Renal Cell Cancer

New York

Bronx New York 10467

A clinical trial to evaluate treatments using RX-0201 and Everolimus for patients with Metastatic Renal Cell Cancer

New York New York 10065

A clinical trial to evaluate treatments using RX-0201 and Everolimus for patients with Metastatic Renal Cell Cancer

New York New York 10032

Patients are needed to participate in a clinical research study evaluating LAG525 and PDR001 for the treatment of Advanced Solid Tumors, Malignancies

New York New York 10065

Patients are needed to participate in a clinical research study evaluating LAG525 and PDR001 for the treatment of Advanced Solid Tumors, Malignancies

New York New York 10021

Patients are needed to participate in a clinical research study of 124IcG250 to evaluate Renal Cancer

North Carolina

Durham North Carolina 27704

Patients are needed to participate in a clinical research study evaluating LAG525 and PDR001 for the treatment of Advanced Solid Tumors, Malignancies

Texas

Houston Texas 77030-4009

Patients are needed to participate in a clinical research study evaluating LAG525 and PDR001 for the treatment of Advanced Solid Tumors, Malignancies

San Antonio Texas 78229

Patients are needed to participate in a clinical research study evaluating LAG525 and PDR001 for the treatment of Advanced Solid Tumors, Malignancies

Utah

Salt Lake City Utah 84112

A clinical trial to evaluate treatments using RX-0201 and Everolimus for patients with Metastatic Renal Cell Cancer

Salt Lake City Utah 84112

Patients are needed to participate in a clinical research study evaluating LAG525 and PDR001 for the treatment of Advanced Solid Tumors, Malignancies

Washington

Seattle Washington 98101

A clinical trial to evaluate treatments using RX-0201 and Everolimus for patients with Metastatic Renal Cell Cancer

Australia

Westmead New South Wales 2145

Patients are needed to participate in a clinical research study evaluating LAG525 and PDR001 for the treatment of Advanced Solid Tumors, Malignancies

Belgium

Leuven 3000

Patients are needed to participate in a clinical research study evaluating LAG525 and PDR001 for the treatment of Advanced Solid Tumors, Malignancies

Canada

Toronto Ontario M5G 2M9

Patients are needed to participate in a clinical research study evaluating LAG525 and PDR001 for the treatment of Advanced Solid Tumors, Malignancies

Italy

Milano MI 20133

Patients are needed to participate in a clinical research study evaluating LAG525 and PDR001 for the treatment of Advanced Solid Tumors, Malignancies

Modena MO 41100

Patients are needed to participate in a clinical research study evaluating LAG525 and PDR001 for the treatment of Advanced Solid Tumors, Malignancies

Japan

Fukuoka 811-1395

Patients are needed to participate in a clinical research study evaluating LAG525 and PDR001 for the treatment of Advanced Solid Tumors, Malignancies

Singapore

Singapore 169610

Patients are needed to participate in a clinical research study evaluating LAG525 and PDR001 for the treatment of Advanced Solid Tumors, Malignancies

Spain

Barcelona Catalunya 08035

Patients are needed to participate in a clinical research study evaluating LAG525 and PDR001 for the treatment of Advanced Solid Tumors, Malignancies

Madrid 28007

Patients are needed to participate in a clinical research study evaluating LAG525 and PDR001 for the treatment of Advanced Solid Tumors, Malignancies